Print

Gene Test Can Cut Warfarin Hospitalizations, Medco Health Solutions, Inc. And Mayo Clinic Study  
3/16/2010 6:58:27 AM

ATLANTA, March 16 /PRNewswire-FirstCall/ -- Hospitalization rates for heart patients taking warfarin, the world's most-prescribed blood thinner, dropped by approximately 30 percent when genetic information was available to doctors prescribing the drug, researchers from Medco Health Solutions, Inc.-- in association with the Medco Research Instituteā„¢ -- and Mayo Clinic announced today. Results of the first nationwide prospective study examining outcomes when incorporating genetic testing into the management of warfarin as part of the usual care of patients were presented today at the American College of Cardiology's 59th annual scientific session and will be published in the Journal of the American College of Cardiology.
//-->